Poland· PL-100079760
Invega
A paliperidone product containing paliperidonum, registered in Poland by Janssen-Cilag International N.V.. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Paliperidone is registered in 17 of 19 countries.
Countries holding a registration under ATC N05AX13 (paliperidone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Paliperidone · ATC N05AX13
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of paliperidone costs, country by country.
Normalised to the WHO defined daily dose (6 mg), the median price runs from $2.75 in Italy to $11.20 in Switzerland — a ×4.1 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Paliperidone · price per daily dose (6 mg)
USD · FX 28 Sept 2026
- CH Switzerland$11.20
- IT Italy$2.75
The record
At a glance
URPL (Poland)- Active substance
- Paliperidonum
- Manufacturer
- Janssen-Cilag International N.V.
- Country
- Poland (PL)
- ATC code
- N05AX13
- ATC class
- Paliperidone
- Defined daily dose
- 6 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 8
- gtin05909990073634
- gtin05909990073641
- gtin05909990073658
- gtin05909990073665
- gtin05909990073672
- gtin05909990073689
- gtin05909990073696
- gtin05909990646708
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
346 interactions on record for paliperidone.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Paliperidone · interactions on record
346 records
- 45 severe
- 252 moderate
- 2 minor
- 14 info
Most severe, free to view
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PasireotideH01CB05severe
33 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Paliperidone in 18 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesINVEGAJanssen Pharmaceuticals, Inc.
- CzechiaINVEGAJanssen-Cilag International N.V., Beerse
- SpainINPALIX 3 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFGKern Pharma S.L.
- SwedenINVEGA 3 mg DepottablettJanssen-Cilag International NV
- BelgiumInvega 3 mgJanssen-Cilag International
- ItalyINVEGAJANSSEN CILAG INTERNATIONAL N.V.
- NetherlandsInvega 3 mg, tablet met verlengde afgifteJanssen-Cilag International NV
- IrelandINVEGA 3 mg prolonged-release tabletsJanssen-Cilag International NV
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Denepra, Palibon
- Belgium · Paliperidon Eg, Paliperidon Krka
- Bulgaria · Егоропал, Палиперидон Тева
- Cyprus · Paliperidon Tad, Paliperidone Palmitate Stada
- Czechia · Balení Pro Zahájení Lécby Psylipax, Dvezlarq
- Germany · Paliperidon 1 A Pharma, Paliperidon Abz
- Denmark · Dopelir, Egoropal
- Estonia · Mopetia, Paliperidone Sandoz
- Spain · Baceq, Dvezlarq
- Finland · Lodixeon, Paliperidon Ratiopharm
- France · Paliperidone Bgr, Paliperidone Biogaran
- United Kingdom (Northern Ireland) · Paliperidone Mylan, Paliperidone Neuraxpharm Uk
- Greece · Dopelir, Paliperidone Palmitate Stada
- Croatia · Arion, Dvezlarq
- Hungary · Egoropal, Paliperidon Actavis
- Ireland · Paliperidone Clonmel, Paliperidone Krka
- Iceland · Byannli, Invega
- Italy · Palbran, Paliperidone Eg
- Liechtenstein · Byannli, Invega
- Lithuania · Paliperidone Sandoz, Paliperidone Teva
- Luxembourg · Paliperidon Ratiopharm, Paliperidone Eg
- Latvia · Mopetia, Paliperidone Sandoz
- Malta · Paliperidone Clonmel
- Netherlands · Paliperidon Cf, Paliperidon Krka
- Norway · Byannli, Invega
- Portugal · Aldesven, Fredexel
- Romania · Mopetia, Paliperidonă Stada
- Sweden · Denepra, Mopetia
- Slovenia · Paliperidon Teva, Paliperidon Vale
- Slovakia · Egoropal, Paliperidón Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/55dce3bb-ec71-4034-8198-da883934b73c GET /v1/drugs/55dce3bb-ec71-4034-8198-da883934b73c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki o przedłużonym uwalnianiu",
"source": "urpl",
"strength": "3 mg",
"packaging": "05909990073634 ¦ Rp ¦ Skasowane ¦ EU/1/07/395/001 ¦ 37938\n28 tabl.\n05909990073641 ¦ Rp ¦ EU/1/07/395/057 ¦ 37939\n30 tabl. w butelce\n05909990073658 ¦ Rp ¦ Skasowane ¦ EU/1/07/395/002 ¦ 37942\n30 tabl. w blistrze\n05909990073665 ¦ Rp ¦ Skasowane ¦ EU/1/07/395/003 ¦ 37943\n49 tabl.\n05909990073672 ¦ Rp ¦ Skasowane ¦ EU/1/07/395/004 ¦ 37946\n56 tabl.\n05909990073689 ¦ Rp ¦ Skasowane ¦ EU/1/07/395/005 ¦ 37947\n98 tabl.\n05909990073696 ¦ Rp ¦ EU/1/07/395/058 ¦ 37948\n350 tabl.\n05909990646708 ¦ Rp ¦ Skasowane ¦ EU/1/07/395/065 ¦ 39222\n14 tabl.\nRp ¦ EU/1/07/395/067 ¦ 131836\n14 tabl.\nRp ¦ Skasowane ¦ EU/1/07/395/066 ¦ 131837\n14 tabl.\nRp ¦ Skasowane ¦ EU/1/07/395/021 ¦ 131838\n28 tabl.\nRp ¦ EU/1/07/395/041 ¦ 131839\n28 tabl.\nRp ¦ Skasowane ¦ EU/1/07/395/022 ¦ 131840\n30 tabl.\nRp ¦ EU/1/07/395/042 ¦ 131841\n49 tabl.\nRp ¦ Skasowane ¦ EU/1/07/395/023 ¦ 131842\n49 tabl.\nRp ¦ Skasowane ¦ EU/1/07/395/024 ¦ 131843\n56 tabl.\nRp ¦ EU/1/07/395/043 ¦ 131844\n59 tabl.\nRp ¦ EU/1/07/395/044 ¦ 131845\n98 tabl.\nRp ¦ Skasowane ¦ EU/1/07/395/025 ¦ 131846\n98 tabl.",
"substance": "Paliperidonum 3 mg",
"common_name": "Paliperidonum",
"pl_product_id": "100079760",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about paliperidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.